Roth Capital Raises Price Target Following Natus Medical's (BABY) 3Q Results

Go back to Roth Capital Raises Price Target Following Natus Medical's (BABY) 3Q Results

Natus Medical (BABY) Tops Q3 EPS by 1c

October 21, 2015 6:07 AM EDT

Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $94.6 million versus the consensus estimate of $93.7 million.

Natus Medical sees Q4 2015 EPS of $0.47-$0.49, versus the consensus of $0.48. Natus Medical sees Q4 2015... More

Trading Radar for 10/21: Coca Cola (KO), GM (GM), AmEx (AXP), Boeing (BA), Kimberly-Clark (KMB) Report

October 20, 2015 2:40 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EDT

MBA Mortgage Index - no Street consensus

Earnings:

A.O. Smith (NYSE: AOS) - consensus EPS $0.79
ABB Ltd. (NYSE: ABB) - consensus EPS $0.28
ARM Holdings plc (NYSE: ARMH) - consensus EPS $0.36
Abbott (NYSE: ABT) - consensus EPS $0.54
Amphenol (NYSE: APH)... More